Properties of an Oral Preparation Containing a Chitosan Salt
The 2-(4-chlorophenoxy)-2-methylpropionic acid (CMP) salt of chitosan (CS), CS-CMP, and that of a CS derivative (CP), were prepared and their ability to adsorb bile acids investigated. CS-CMP and CP-CMP rapidly adsorbed taurocholate (TCA) and glycocholate (GCA) when these bile acids were present tog...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2009-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/14/2/755/ |
id |
doaj-a3658fff91a740a2817950b67dfb5e8b |
---|---|
record_format |
Article |
spelling |
doaj-a3658fff91a740a2817950b67dfb5e8b2020-11-24T22:45:56ZengMDPI AGMolecules1420-30492009-02-0114275576210.3390/molecules14020755Properties of an Oral Preparation Containing a Chitosan SaltSusumu KawashimaKyouko KofujiDaijirou HiraiYouko KodamaYoshifumi MurataThe 2-(4-chlorophenoxy)-2-methylpropionic acid (CMP) salt of chitosan (CS), CS-CMP, and that of a CS derivative (CP), were prepared and their ability to adsorb bile acids investigated. CS-CMP and CP-CMP rapidly adsorbed taurocholate (TCA) and glycocholate (GCA) when these bile acids were present together in the medium, with simultaneous release of CMP. A secondary bile acid, taurodeoxycholate, was preferentially adsorbed over TCA and GCA. Alginate gel beads containing CS-CMP did not differ from CS-CMP alone in their manner of bile acids take up. Furthermore, oral administration of CS-CMP to rats resulted in decreased serum cholesterol and triacylglycerol levels for two weeks. Therefore, CS-CMP, as well as a vehiclecontaining CS-CMP, might be a useful agent with which to treat hyperlipidemia http://www.mdpi.com/1420-3049/14/2/755/Chitosan2-(4-Chlorophenoxy)-2-methylpropionic acidBile acid adsorptionDrug releaseHyperlipidemia |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Susumu Kawashima Kyouko Kofuji Daijirou Hirai Youko Kodama Yoshifumi Murata |
spellingShingle |
Susumu Kawashima Kyouko Kofuji Daijirou Hirai Youko Kodama Yoshifumi Murata Properties of an Oral Preparation Containing a Chitosan Salt Molecules Chitosan 2-(4-Chlorophenoxy)-2-methylpropionic acid Bile acid adsorption Drug release Hyperlipidemia |
author_facet |
Susumu Kawashima Kyouko Kofuji Daijirou Hirai Youko Kodama Yoshifumi Murata |
author_sort |
Susumu Kawashima |
title |
Properties of an Oral Preparation Containing a Chitosan Salt |
title_short |
Properties of an Oral Preparation Containing a Chitosan Salt |
title_full |
Properties of an Oral Preparation Containing a Chitosan Salt |
title_fullStr |
Properties of an Oral Preparation Containing a Chitosan Salt |
title_full_unstemmed |
Properties of an Oral Preparation Containing a Chitosan Salt |
title_sort |
properties of an oral preparation containing a chitosan salt |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2009-02-01 |
description |
The 2-(4-chlorophenoxy)-2-methylpropionic acid (CMP) salt of chitosan (CS), CS-CMP, and that of a CS derivative (CP), were prepared and their ability to adsorb bile acids investigated. CS-CMP and CP-CMP rapidly adsorbed taurocholate (TCA) and glycocholate (GCA) when these bile acids were present together in the medium, with simultaneous release of CMP. A secondary bile acid, taurodeoxycholate, was preferentially adsorbed over TCA and GCA. Alginate gel beads containing CS-CMP did not differ from CS-CMP alone in their manner of bile acids take up. Furthermore, oral administration of CS-CMP to rats resulted in decreased serum cholesterol and triacylglycerol levels for two weeks. Therefore, CS-CMP, as well as a vehiclecontaining CS-CMP, might be a useful agent with which to treat hyperlipidemia |
topic |
Chitosan 2-(4-Chlorophenoxy)-2-methylpropionic acid Bile acid adsorption Drug release Hyperlipidemia |
url |
http://www.mdpi.com/1420-3049/14/2/755/ |
work_keys_str_mv |
AT susumukawashima propertiesofanoralpreparationcontainingachitosansalt AT kyoukokofuji propertiesofanoralpreparationcontainingachitosansalt AT daijirouhirai propertiesofanoralpreparationcontainingachitosansalt AT youkokodama propertiesofanoralpreparationcontainingachitosansalt AT yoshifumimurata propertiesofanoralpreparationcontainingachitosansalt |
_version_ |
1725686955221450752 |